Skip to main content
X

THANK YOU

Welcome to the diaTribe community!

If you have any questions or comments, please don't hesitate to contact us at comments@diaTribe.org.

Recommend diaTribe

If you know somebody who is affected by diabetes and who might benefit from the information diaTribe provides, tell them about us through Facebook, Twitter, or email.

Standards of Care Updates from the ADA

New updates include the recommendation of GLP-1 agonists and SGLT-2 inhibitors for heart and kidney protection, earlier combination therapy in type 2 diabetes, GLP-1 agonists as first-line injection therapy, and CGM metrics Continue Reading